Here's the live share price of Venus Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Venus Remedies has gained 24.98% CAGR. Over the past year, the corresponding return has been 24.45%.
Venus Remedies’s current P/E of 10.65x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Venus Remedies | -5.47 | -9.98 | 0.26 | 45.04 | 24.45 | 23.69 | 24.98 |
Sun Pharmaceutical Industries | 2.83 | 2.20 | 0.89 | -4.12 | -9.99 | 23.87 | 26.97 |
Divi's Laboratories | 3.00 | 2.05 | -4.40 | 6.71 | 14.20 | 19.70 | 14.46 |
Cipla | -0.59 | 1.00 | 5.48 | 4.40 | -4.52 | 14.77 | 15.30 |
Torrent Pharmaceuticals | 1.58 | -0.76 | 14.35 | 13.47 | 8.11 | 34.79 | 21.79 |
Dr. Reddy's Laboratories | 0.35 | 6.08 | -0.41 | 12.72 | 1.51 | 17.24 | 5.15 |
Mankind Pharma | 2.33 | 5.96 | 13.66 | 22.14 | 8.60 | 22.85 | 13.14 |
Zydus Lifesciences | -0.55 | 5.07 | 9.40 | 14.24 | -1.45 | 42.42 | 21.27 |
Lupin | 0.55 | 4.36 | 6.29 | -0.33 | -5.35 | 47.39 | 14.56 |
Alkem Laboratories | 1.29 | 2.36 | 15.48 | 13.69 | -10.12 | 19.34 | 14.00 |
Abbott India | -0.27 | -6.60 | -0.43 | 1.80 | 10.43 | 21.10 | 14.21 |
Aurobindo Pharma | 2.68 | 3.09 | 3.76 | -3.41 | -26.41 | 29.32 | 7.28 |
Glenmark Pharmaceuticals | -1.58 | 7.76 | 27.87 | 41.06 | 27.00 | 78.19 | 34.68 |
Laurus Labs | 4.54 | 5.86 | 45.00 | 54.55 | 99.17 | 22.66 | 26.83 |
Biocon | 1.21 | 1.51 | 6.00 | 8.14 | 2.43 | 8.40 | -2.94 |
Anthem Biosciences | 1.29 | 3.17 | 15.57 | 15.57 | 15.57 | 4.94 | 2.94 |
GlaxoSmithKline Pharmaceuticals | -0.92 | -2.42 | -13.92 | -3.03 | 1.87 | 24.90 | 10.16 |
Cohance Lifesciences | -6.81 | -0.56 | -7.50 | -21.23 | -22.36 | 25.78 | 19.28 |
Ipca Laboratories | 3.59 | -1.71 | 0.08 | 0.46 | -6.31 | 16.67 | 5.51 |
Gland Pharma | -0.11 | 3.78 | 18.16 | 27.54 | 11.50 | -3.48 | 2.09 |
Over the last one year, Venus Remedies has gained 24.45% compared to peers like Sun Pharmaceutical Industries (-9.99%), Divi's Laboratories (14.20%), Cipla (-4.52%). From a 5 year perspective, Venus Remedies has outperformed peers relative to Sun Pharmaceutical Industries (26.97%) and Divi's Laboratories (14.46%).
Day | SMA | EMA |
---|---|---|
5 | 450.24 | 449.94 |
10 | 455.83 | 455.2 |
20 | 466.43 | 463.94 |
50 | 486.23 | 466.64 |
100 | 438.46 | 440.96 |
200 | 373.79 | 402.5 |
In the latest quarter, Venus Remedies remained same as its previous close in promoter holding, while DII stake increased to 0.11%, FII holding rose to 2.25%, and public shareholding moved down to 55.89% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 11, 2025, 5:17 PM IST | Venus Remedies L - Social Media Post On Saksham Niveshak Campaign By IEPF. |
Aug 27, 2025, 3:29 PM IST | Venus Remedies L - Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shar |
Aug 23, 2025, 9:55 PM IST | Venus Remedies L - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Aug 23, 2025, 5:18 PM IST | Venus Remedies L - Special Window For Re-Lodgement Of Transfer Requests OfPhysical Shares - Report For July 2025 |
Aug 23, 2025, 5:10 PM IST | Venus Remedies L - Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares - Report For July 2025 |
Venus Remedies Ltd. is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 639.46 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Venus Remedies is ₹428.00 as on Sep 19, 2025.
The Venus Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Venus Remedies is ₹572.11 Cr as on Sep 19, 2025.
Today’s highest and lowest price of Venus Remedies are ₹439.15 and ₹428.00.
The 52-week high/low is the highest and lowest price at which Venus Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Venus Remedies is ₹565.95 and 52-week low of Venus Remedies is ₹272.20 as on Sep 19, 2025.
The Venus Remedies has shown returns of -1.62% over the past day, -9.98% for the past month, 0.26% over 3 months, 24.45% over 1 year, 23.69% across 3 years, and 24.98% over 5 years.
P/E ratio of and PB ratio of Venus Remedies are 10.65 and 1.16 on Sep 19, 2025. While the company gives a dividend yield of 0.00 per annum.